Maha Farhat
Maha Farhat, MD, MSc
Assistant Professor of Biomedical Informatics, Harvard Medical School
10 Shattuck Street #307, Boston, MA 02115

Maha Farhat  holds an MD from the McGill University Faculty of Medicine and a MSc in biostatistics from the Harvard Chan School of Public Health. She is also a practicing physician at the Massachusetts General Hospital Division of Pulmonary and Critical Care Medicine.

Dr. Farhat's research focuses on the development and application of methods for associating genotype and phenotype in infectious disease pathogens, with a strong emphasis on translation to better diagnostics and surveillance in resource-poor settings. To date, Farhat's work has focused on the pathogen Mycobacterium tuberculosis and spans the spectrum from computational analysis to field studies. She is PI and Co-Investigator on several large projects funded by NIH including the NIAID and the BD2K initiative.

DBMI Research Areas
DBMI Courses
Tuberculosis Pathways to Care and Transmission of Multidrug-Resistance in India.
Authors: Atre SR, Jagtap JD, Faqih MI, Dumbare YK, Sawant TU, Ambike SL, Bhawalkar JS, Bharaswadkar SK, Jogewar PK, Adkekar RS, Hodgar BP, Jadhav V, Mokashi ND, Golub JE, Dixit A, Farhat MR.
Am J Respir Crit Care Med
View full abstract on Pubmed
Population structure, biogeography and transmissibility of Mycobacterium tuberculosis.
Authors: Freschi L, Vargas R, Husain A, Kamal SMM, Skrahina A, Tahseen S, Ismail N, Barbova A, Niemann S, Cirillo DM, Dean AS, Zignol M, Farhat MR.
Nat Commun
View full abstract on Pubmed
Role of Epistasis in Amikacin, Kanamycin, Bedaquiline, and Clofazimine Resistance in Mycobacterium tuberculosis Complex.
Authors: Vargas R, Freschi L, Spitaleri A, Tahseen S, Barilar I, Niemann S, Miotto P, Cirillo DM, Köser CU, Farhat MR.
Antimicrob Agents Chemother
View full abstract on Pubmed
Association Between NEDD4L Variation and the Genetic Risk of Acute Appendicitis: A Multi-institutional Genome-Wide Association Study.
Authors: Gaitanidis A, Kaafarani HMA, Christensen MA, Breen K, Mendoza A, Fagenholz PJ, Velmahos GC, Farhat MR.
View full abstract on Pubmed
Fecal microbiota transplantation and Clostridioides difficile infection among privately insured patients in the United States.
Authors: El Halabi J, Palmer N, Fox K, Kohane I, Farhat MR.
J Gastroenterol
View full abstract on Pubmed
GenTB: A user-friendly genome-based predictor for tuberculosis resistance powered by machine learning.
Authors: Gröschel MI, Owens M, Freschi L, Vargas R, Marin MG, Phelan J, Iqbal Z, Dixit A, Farhat MR.
Genome Med
View full abstract on Pubmed
Diagnostic deficiencies of C. difficile infection among patients in a tertiary hospital in Saudi Arabia: A laboratory-based case series.
Authors: AlJindan R, AlEraky DM, Borgio JF, AbdulAzeez S, Abdalhamid B, Mahmoud N, Farhat M.
Saudi J Biol Sci
View full abstract on Pubmed
Measuring health-care delays among privately insured patients with tuberculosis in the USA: an observational cohort study.
Authors: El Halabi J, Palmer N, McDuffie M, Golub JJ, Fox K, Kohane I, Farhat MR.
Lancet Infect Dis
View full abstract on Pubmed
Multisystem outcomes and predictors of mortality in critically ill patients with COVID-19: Demographics and disease acuity matter more than comorbidities or treatment modalities.
Authors: Alser O, Mokhtari A, Naar L, Langeveld K, Breen KA, El Moheb M, Kapoen C, Gaitanidis A, Christensen MA, Maurer LR, Mashbari H, Bankhead-Kendall B, Parks J, Fawley J, Saillant N, Mendoza A, Paranjape C, Fagenholz P, King D, Lee J, Farhat MR, Velmahos GC, Kaafarani HMA.
J Trauma Acute Care Surg
View full abstract on Pubmed
Globally diverse Mycobacterium tuberculosis resistance acquisition: a retrospective geographical and temporal analysis of whole genome sequences.
Authors: Ektefaie Y, Dixit A, Freschi L, Farhat MR.
Lancet Microbe
View full abstract on Pubmed